POST 00441E : IMPACT OF VACCINE VIAL MONITORS (VVM) ON THE USE and DELIVERY OF MEASLES VACCINE

POST 00441E : IMPACT OF VACCINE VIAL MONITORS (VVM) ON THE USE and DELIVERY OF MEASLES VACCINE Follow-up on Post 00433E 31 March 2002 ________________________________________________________________________________ Post 00433E has generated some questions and comments. First from Femi Oyewole of WHO/Ethiopia ------------------------------------------------ "Thanks for sharing this study proposal with us. Experience with OPV with VVM has shown that changes do occur faster in some tropical areas where ambient temperatures can be as high as over 40 degrees celsius. Can we start looking at the behavior of the "measles VVM" before it becomes generally available? This may help us determine how far we can "stretch" the chain. Or has this been taken into consideration? Another point- how easily does the label come/peel off ?" Femi Oyewole EPI Team Leader, WHO/Ethiopia ------------------------------------------------ Then from Emmanuel Taylor also from WHO ------------------------------------------------ "The study will be quite useful. A change in behavior due to different climatic environment will also be our interest in Kenya as we hope to conduct a nation-wide measles campaign during seven days in mid-June. I am told the measles vaccines may be coming with VVM. Kenya is targeting about 15,000,000 children during the seven-day campaign. Within this period, we will need about 19.5 million doses. We must have in place effective storage and distribution systems. The importance of VVM on the vials becomes evident. So, if they come with vials, we shall give feedback to all on its effectiveness, use and management." ------------------------------------------------- Finally a comment from Mike Levine from the University of Maryland "This is very exciting. These studies make opportunistic use of a unique situation and will likely yield invaluable practical data. Well done to all concerned!!" Myron M. Levine, M.D., D.T.P.H. Professor and Director University of Maryland School of Medicine Center for Vaccine Development ----------------------------------------------------------------------------- CONTRIBUTIONS Contributions to or use your reply button! The TechNet21 e-Forum welcomes new subscribers who are involved in immunization services. SUBCRIBE To subscribe, send an e-mail to Leave the SUBJECT area BLANK, do not type anything. In the body text, just write : Subscribe TECHNET21E Surname Name Do not use any accents in your name and surname. UNSUBSCRIBE To unsubscribe, send an e-mail to Leave the SUBJECT area BLANK, do not type anything. In the body text, just write : Unsubscribe TECHNET21E ------------------------------------------------------------------------------ ARCHIVES New archives of posted messages starting with 1 November 2001 is accessible to all TechNet21 subscribers. To view the archives http://listes.ulaval.ca/listserv/archives/technet21e.html Archives for postings between 17 August 1998 and 31 October 2001 can be found at the following web site for download starting 1 December 2001. http//http://www.who.int/vaccines-access/Vaccines/Vaccine_Cold_Chain/Technet Archives for files (documents) are under revision to clean old documents and drafts that are already replaced with new ones, and will be made available soon at the same site. http//http://www.who.int/vaccines-access/Vaccines/Vaccine_Cold_Chain/Technet ----------------------------------------------------------------------------- The World Health Organization and UNICEF support TechNet21. The TechNet21 e-Forum is a communication/information tool for generation of ideas on how to improve immunization services.